News
Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...
Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...
Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...
Richard Lepke; Senior Director, Investor Relations; Vir Biotechnology Inc. Marianne De Backer; Chief Executive Officer, Director; Vir Biotechnology Inc. Mark Eisner; ...
Discover a recent study presented at EASL 2025 that explored the impact of opt-out testing for blood-borne viruses in ...
Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.
Oklahoma scientists find interferon-beta may help MS patients on B cell therapy fight infections like flu and Covid-19, new ...
Autolus reported Q1 2025 net product sales of $9.0 million. The Company has 39 centers fully activated in the U.S. as of May 7, 2025. Patient access to AUCATZYL continues to increase, with coverage ...
As of 2022, an estimated 50 million people globally were infected with chronic hepatitis C virus (HCV), with an estimated 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results